Alloimmunization screening after transfusion of red blood cells in a prospective study
- PMID: 23049421
- PMCID: PMC3459635
- DOI: 10.5581/1516-8484.20120051
Alloimmunization screening after transfusion of red blood cells in a prospective study
Erratum in
-
Erratum to "Alloimmunization screening after transfusion of red blood cells in a prospective study" [Rev Bras Hematol Hemoter. 2012;34(3):206-211].Rev Bras Hematol Hemoter. 2017 Apr-Jun;39(2):186. doi: 10.1016/j.bjhh.2017.04.001. Rev Bras Hematol Hemoter. 2017. PMID: 28577661 Free PMC article. No abstract available.
Abstract
Background: Several irregular red blood cell alloantibodies, produced by alloimmunization of antigens in transfusions or pregnancies, have clinical importance because they cause hemolysis in the fetus and newborn and in transfused patients.
Objective: a prospective analysis of patients treated by the surgical and clinical emergency services of Hospital de Clínicas of the Universidade Federal do Triângulo Mineiro (HC/UFTM), Brazil was performed to correlate alloimmunization to clinical and epidemiological data.
Methods: Blood samples of 143 patients with initial negative antibody screening were collected at intervals for up to 15 months after the transfusion of packed red blood cells. Samples were submitted to irregular antibody testing and, when positive, to the identification and serial titration of alloantibodies. The Fisher Exact test and Odds Ratio were employed to compare proportions.
Results: Fifteen (10.49%) patients produced antibodies within six months of transfusion. However, for 60% of these individuals, the titers decreased and disappeared by 15 months after transfusion. Anti-K antibodies and alloantibodies against antigens of the Rh system were the most common; the highest titer was 1:32 (anti-K). There was an evident correlation with the number of transfusions.
Conclusions: Given the high incidence of clinically important red blood cell alloantibodies in patients transfused in surgical and clinical emergency services, we suggest that phenotyping and pre-transfusion compatibilization for C, c, E, e (Rh system) and K (Kell system) antigens should be extended to all patients with programmed surgeries or acute clinical events that do not need emergency transfusions.
Keywords: Blood group antigens; Blood transfusion; Emergencies; Hemolysis; Immunophenotyping.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interest
Figures
References
-
- Novaretti MC.Investigação laboratorial em pacientes com anticorpos eritrocitários In: Bordin JO, Langhi Júnior DM, Covas DT.Hemoterapia: fundamentos e prática. São Paulo: Atheneu; 2007. p 186-89
-
- Baptista-González HA, Rosenfeld-Mann F, Pérez-Pérez JD, Quintanar-Garcia E.Anticuerpos irregulares antieritrocitarios fuera del sistema ABO en el periodo perínatal. Bol Med Hosp Infant Mex. 1991; 48(11): 814-9 - PubMed
-
- Lee CK, Ma ES, Tang M, Lam CC, Lin CK, Chan LC.Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy - a review of cases from 1997 to 2001. Transfus Med. 2003; 13(4): 227-31 - PubMed
-
- Serrano J.Incidencia y caracterización de anticuerpos eritrocitários en un banco de sangre hospitalario. Sangre (Barc). 1990; 35(5): 363-8 - PubMed
-
- Redman M, Regan F, Contreras M.A prospective study of the incidence of red cell alloimmunization following transfusion. Vox Sang. 1996; 71(4): 216-20 - PubMed
LinkOut - more resources
Full Text Sources